Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Organ-on-a-Chip and Body-on-a-Chip: In Vitro Systems Mimicking In Vivo Functions

K. Scott Phillips's Biography



K. Scott Phillips, Biofilms Research Group Leader, US FDA Center for Devices and Radiological Health

Kenneth “Scott” Phillips is Biofilms Research Group Leader in the FDA Center for Devices and Radiological Health (CDRH), Office of Science and Engineering Laboratories (OSEL), Division of Biology, Chemistry and Materials Science (DBCMS), at the White Oak Federal Research Center. He did PhD research in Analytical Chemistry at the University of California, Riverside, and an NIH Postdoctoral Fellowship in Chemistry/Biomedical Engineering at the University of North Carolina, Chapel Hill. He has over 30 publications in analytical chemistry and biomaterials. Some of his most significant research achievements are the development of the first heterogeneous microfluidic immunoassay, work on patterned nanoglassified surface plasmon resonance (SPR) substrates, and the development of the first continuous single cell analysis-on-a-chip based on laser lysis and electrophoresis. Dr. Phillips has been researching medical device associated infections at the FDA for over 6 years now, performs about 40 consults per year to assist with regulatory review of medical devices, and is involved in a number of regulatory science efforts in CDRH.

K. Scott Phillips Image

Medical Device-on-a-Chip: The Future of Performance and Safety Testing?

Friday, 8 July 2016 at 08:30

Add to Calendar ▼2016-07-08 08:30:002016-07-08 09:30:00Europe/LondonMedical Device-on-a-Chip: The Future of Performance and Safety Testing?SELECTBIOenquiries@selectbiosciences.com

Organ-on-a-chip models combine lab-on-a-chip technology with tissue culture techniques to more accurately mimic human physiology. In the field of pharmaceuticals, organ-on-a-chip in vitro models have seen rapid development. Although medical devices and pharmaceuticals have a number of similar testing needs, there has been no recognition of the potential for lab-on-a-chip models to transform performance and/or safety testing of medical devices. In this talk, we will describe the potential advantages of medical-device-on-a-chip (MDOC) technology to help increase the speed of performance and safety testing for medical devices, while decreasing the overall burden required to bring new technologies to market. We will discuss efforts in our laboratory to miniaturize current test methods, and  solutions that were developed to overcome unique challenges associated with combining macroscale device materials and microscale fluidics.


Add to Calendar ▼2016-07-07 00:00:002016-07-08 00:00:00Europe/LondonOrgan-on-a-Chip and Body-on-a-Chip: In Vitro Systems Mimicking In Vivo FunctionsSELECTBIOenquiries@selectbiosciences.com